Skip to main content
Journal of the Egyptian National Cancer Institute

Table 2 Association between telomere length in breast cancer patients in various stages and control groups Telomere

From: Impact of DAXX and ATRX expression on telomere length and prognosis of breast cancer patients

 

n of cases (%)

Telomere length (mean ± SD)

P

Control group

100

26.2587 ± 0.23

 

0.001*

Breast cancer patients

220

40.8372 ± 0.81

0.006#

 Stage I and stage IIA

70 (31.8%)

46.8343 ± 1.18

 Stage IIB–stage IIIC

150 (86.2%)

31.8400 ± 0.73

  1. One-way ANOVA test was used for this association. # obtained by least significant difference (LSD) of post hoc of ANOVA test
  2. SD standard deviation
  3. *Significant
Back to article page